Jacobs Bruce N.

Kymera Therapeutics, Inc. ยท Chief Financial Officer

Jacobs Bruce N. is listed in public filings as officer: Chief Financial Officer. This Jacobs Bruce N. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Kymera Therapeutics, Inc. (KYMR). Investors use Jacobs Bruce N.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Kymera Therapeutics, Inc.KYMR$012.7k sharesGrant / ExerciseJun 2, 2026$26.3K12.7k shares$2.08--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Kymera Therapeutics, Inc.KYMR$26k12.7k sharesGrant / ExerciseMay 18, 2026$31.2K15k shares$2.08--
Kymera Therapeutics, Inc.KYMR$20M234.5k sharesSellMar 4, 2026$214.2K2.5k shares$85.04--
Kymera Therapeutics, Inc.KYMR$20M233k sharesSellMar 4, 2026$123.3K1.4k shares$85.78--
Kymera Therapeutics, Inc.KYMR$20M237k sharesSellMar 4, 2026$41.3K492 shares$84.00--
Kymera Therapeutics, Inc.KYMR$20M232.6k sharesSellMar 4, 2026$38.7K447 shares$86.62--
Kymera Therapeutics, Inc.KYMR$3.2M35.3k sharesGrant / ExerciseMar 2, 2026$3.2M35.3k shares$90.10--
Kymera Therapeutics, Inc.KYMR$21M237.5k sharesSellMar 2, 2026$368.8K4.1k shares$89.66--
Kymera Therapeutics, Inc.KYMR--245.1k sharesGrant / ExerciseMar 2, 2026Disclosure amount unavailable17.7k shares----
Kymera Therapeutics, Inc.KYMR$21M243k sharesSellMar 2, 2026$178.9K2k shares$87.75--
Kymera Therapeutics, Inc.KYMR$21M241.6k sharesSellMar 2, 2026$126.0K1.4k shares$88.50--
Kymera Therapeutics, Inc.KYMR$11M227.4k sharesSellSep 17, 2025$4.0M79.2k shares$50.00--
Kymera Therapeutics, Inc.KYMR$638k306.6k sharesGrant / ExerciseSep 17, 2025$164.8K79.2k shares$2.08--
Kymera Therapeutics, Inc.KYMR$58k27.7k sharesGrant / ExerciseSep 17, 2025$87.9K42.2k shares$2.08--
Kymera Therapeutics, Inc.KYMR$037k sharesGrant / ExerciseSep 17, 2025$76.9K37k shares$2.08--
Kymera Therapeutics, Inc.KYMR$145k69.9k sharesGrant / ExerciseMar 31, 2025$52.0K25k shares$2.08--
Kymera Therapeutics, Inc.KYMR$1.8M60k sharesGrant / ExerciseMar 3, 2025$1.8M60k shares$30.17--
Kymera Therapeutics, Inc.KYMR--208.9k sharesGrant / ExerciseMar 3, 2025Disclosure amount unavailable30k shares----
Kymera Therapeutics, Inc.KYMR$6.2M203.2k sharesSellMar 3, 2025$174.5K5.8k shares$30.33--
Kymera Therapeutics, Inc.KYMR$6.3M201.9k sharesSellMar 3, 2025$39.7K1.3k shares$31.00--
Kymera Therapeutics, Inc.KYMR$197k94.9k sharesGrant / ExerciseJan 10, 2025$20.8K10k shares$2.08--